The Global Genes Next 2021 Report: A Time for Resilience and Ingenuity, written by Daniel Levine is complete and available from Global Genes. The report covers major developments of 2020 and the top trends that are reshaping the rare disease landscape. Click the link below to access the report.
Related
RARE-X Insights & Recommendations for Organizational DEI Strategies Study
Ensuring diversity, equity, and inclusion in rare disease organizations requires focused programs that engage all stakeholders. A […]
Read moreRARE Health Equity Report: Building a More Inclusive Rare Disease Community
For communities of color and other minoritized populations, finding and connecting with others in their disease community, […]
Read more2019 NEXT: Imagining the Future of Rare Disease
The pace of innovation continues to accelerate, thanks in no small measure to the growing sophistication of […]
Read moreRARE Drug Development 2020 Report
RARE Drug Development Report This year began with hope for the future and advancements in rare […]
Read moreNEXT 2023: The Rise of the Impatient Advocate
As Global Genes begins the year with an expanded focus on enabling next-generation patient advocacy, following its […]
Read moreNEXT 2022 – Redefining the Possible
Download your free copy of NEXT 2022. This report forecasts the developments, trends, and the progress being […]
Read more2021 Platforms of Hope – Realizing the Potential of Genetic Medicines
This report is the culmination of a year-long Global Genes multimedia reporting series in collaboration with the […]
Read moreNEXT 2021: A Time for Resilience and Ingenuity
Global Genes Next 2021 Report: A Time for Resilience and Ingenuity February 2021 The Global Genes Next 2021 Report: […]
Read more